Rofecoxib is a nonsteroidal anti-inflammatory drug that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea.
Formerly marketed by Merck & Co.
under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke..
For more information about the topic Rofecoxib, read the full article at Wikipedia.org, or see the following related articles:
COX-2 inhibitor COX-2 selective inhibitor is a form of Non-steroidal anti-inflammatory drug (NSAID) that directly targets COX-2, an enzyme responsible for ... >
read more
Analgesic An analgesic (colloquially known as painkillers) is any member of the diverse group of drugs used to relieve pain and to achieve analgesia. This ... >
read more
Clinical trial The most commonly performed clinical trials evaluate new drugs, medical devices, biologics, or other interventions to patients in strictly ... >
read more
Osteoarthritis Osteoarthritis (OA, also known as degenerative arthritis or degenerative joint disease, and sometimes referred to as "arthrosis" or ... >
read more
Note: This page refers to an article that is licensed under the GNU Free Documentation License. It uses material from the article Rofecoxib at Wikipedia.org. See the Wikipedia copyright page for more details.